Symptom Assessment in Adolescents Placed on Child Welfare

This study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD).

As emotional dysregulation is a dynamic process whose phenomenological manifestations are labile, associated with physiological modifications and modulated by cognitive processing, a multiple methodology associating measurements in a real-life ecological context with measurements performed in the hospital will be preferred.

Overall, this study proposes to capture, for the first time, the clinical manifestations associated with cPTSD from the perspective of emotional dysregulation and its underlying processes

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Complex Post-Traumatic Stress Disorder (CPTSD) Borderline Personality Disorder Borderline Personality Disorder (BPD) Combat Disorders Mental Disorders Personality Disorders Post-Traumatic Stress Disorder, PTSD Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

12 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpitaux Universitaires de Strasbourg

Strasbourg, Grand Est, 67000, France

Location status: Recruiting

Location contact

Carmen SCHRÖDER

CONTACT

[email protected]

0033388115248

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adolescent aged 12 to 17
Entrusted to ASE Bas-Rhin.
Fluent in French
Affiliated with a social health insurance scheme
Agreeing to take part in the study
Legal representative of the minor or his/her guardian, or his/her representative from the ASE agreeing to take part in the study.

Exclusion criteria

Adolescent refusing to participate in the study
Legal representative of the minor or his/her guardian, or his/her ASE representative refusing to participate in the study
Adolescent with severe developmental delay
Adolescent participating in another research study
Adolescent deprived of liberty by judicial or administrative decision

Treatment and study plan

Primary outcomes

Prevalence of post-traumatic stress disorder (PTSD) according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria

Time frame: From inclusion to the end (6 months)

PTSD will be assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria, using the Child Post-Traumatic Checklist (CPC-P). The outcome will be the proportion of participants meeting DSM-5 diagnostic criteria for PTSD.
Prevalence of complex post-traumatic stress disorder (CPTSD) according to International Classification of Diseases, 11th Revision (ICD-11) criteria

Time frame: From inclusion to 6 months

Complex post-traumatic stress disorder (CPTSD) will be assessed according to the International Classification of Diseases, 11th Revision (ICD-11) diagnostic criteria, using the Child and Adolescent Trauma Screen (CATS). The outcome will be the proportion of participants meeting ICD-11 diagnostic criteria for CPTSD.

Study contacts

Contact information is provided by the study sponsor or research team.

Carmen SCHRÖDER

CONTACT

[email protected]

0033388115248

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Evaluation of Post-traumatic and Neurodevelopmental Symptoms in Adolescents Placed in Child Welfare

Acronym: PePsAdoTND

Important dates

Study start: 2026
Primary completion: 2027
Study completion: 2028
First posted: Aug 31, 2026
Registry last updated: Aug 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed